GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity ...Middle East

The use of GLP-1s is linked to improved inflammatory bowel disease outcomes in patients with concomitant inflammatory bowel disease and type 2 diabetes, specifically in those with obesity. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity )

Also on site :

• At Least 11 Dead After Driver Plowed Into Crowd at a Filipino Festival in Vancouver
• Fragile peace shattered: Kashmir attack pushes India, Pakistan to brink
• Trump says 'confines of a deal' are there on Ukraine / Russia